Knight Therapeutics | GUD - 净收入

股票价格

7.54

每天变化

0.08 1.07%

每月一次

6.05%

每年

27.80%

Q2 预测

7.49

金融业

CAD

CAD 1.05B

现金及等价物

CAD 76.45M

CAD 82.22M

CAD 394.84M

CAD 165.26M

CAD 77.91M

CAD 6.21M

CAD 24.45M

698

EPS每股收益

CAD -0.09

股本和储备

CAD 767.27M

CAD 64.72M

债务利息支出

CAD 3.92M

CAD 2.46M

CAD 57.78M

CAD 757.77M

CAD -3.79M

CAD 126.9M

CAD 6.21M

普通股股本

CAD 99.68M

257.34

CAD -1.92M

CAD 133.11M

销售和管理费用

CAD 35.45M

CAD 95.4M

贸易债权人

CAD 125.76M

应收帐款人

CAD 183M

	净收入	更改		日
Acasti Pharma	USD -938K		2.42M	2025-09
Akebia Therapeutics	USD -12.24M		12.78M	2025-12
Alaunos Therapeutics	USD -1.16M		108K	2025-09
Aurora Cannabis	CAD 1.82M		53.29M	2025-12
Avita Medical	AUD -11.62M		1.7M	2025-12
Canopy Growth	CAD -62.63M		60.99M	2025-12
Cronos Group	USD -1.82M		24.14M	2025-12
Dianthus Therapeutics	USD -64.43M		27.67M	2025-12
Ionis Pharmaceuticals	USD -229M		100.39M	2025-12
IQVIA Holdings	USD 514M		183M	2025-12
Knight Therapeutics	CAD -3.79M		8.83M	2025-09
Moderna	USD -200M		625M	2025-09
Omeros	USD -32.23M		23.81M	2024-09
Organigram Holdings	CAD 19.97M		57.93M	2025-12
Organon & Co	USD 160M		15M	2025-09
Revvity	USD 98.36M		51.71M	2025-12
Tectonic Therapeutic	USD -19.23M		186K	2025-12
Tilray	USD -44.93M		44.61M	2025-09
Viatris	USD -340.1M		211.9M	2025-12
Xeris Pharmaceuticals	USD 11.08M		10.46M	2025-12